Effect of the Neuraminidase Mutation H274Y Conferring Resistance to Oseltamivir on the Replicative Capacity and Virulence of Old and Recent Human Influenza A(H1N1) Viruses

被引:105
作者
Baz, Mariana
Abed, Yacine
Simon, Philippe
Hamelin, Marie-Eve
Boivin, Guy
机构
[1] Ctr Hosp Univ Quebec, Res Ctr Infect Dis, Quebec City, PQ, Canada
[2] Univ Laval, Quebec City, PQ, Canada
基金
加拿大健康研究院;
关键词
A H1N1 VIRUSES; UNITED-STATES; IN-VITRO; TRANSMISSION; SUSCEPTIBILITY; INFECTIONS; INHIBITORS; SEASON;
D O I
10.1086/650464
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. The viral fitness of neuraminidase inhibitor (NAI)-resistant influenza viruses is believed to be impaired. Unexpectedly, an oseltamivir-resistant A(H1N1) variant containing the H274Y neuraminidase (NA) mutation recently disseminated worldwide, suggesting that the replication and virulence properties of this mutant virus were not compromised. Methods. In vitro replicative capacities were determined for old (A/WSN/33, A/Mississipi/3/01, A/New Caledonia/ 20/99, and A/Solomon Islands/03/06) and recent (A/Brisbane/59/2007-like) influenza A(H1N1) viruses either harboring or not harboring the H274Y NA mutation. Ferrets were infected with the A/Brisbane/59/2007-like wild-type (WT) isolate and its H274Y NA variant. Results. Old A(H1N1) WT viruses grew at higher titers than did the A/Brisbane/59/2007-like viruses in vitro. The H274Y mutation was associated with reduced viral plaque areas in cells infected with A/WSN/33 and A/Mississippi/3/01, whereas the 2 A/Brisbane/59/2007-like isolates showed similar plaque sizes. In ferrets, the pyrexic response induced by the A/Brisbane/59/2007-like H274Y mutant was significantly higher than that induced by the WT isolate. Nasal wash viral titers were significantly greater for the mutant isolate on day 2 after inoculation, whereas the 2 viruses showed similar titers between days 3 and 7 after inoculation. Conclusions. The viral fitness of the recent A/Brisbane/59/2007-like H274Y variant is not impaired, consistent with its global dissemination. These results reinforce the need for new antiviral strategies.
引用
收藏
页码:740 / 745
页数:6
相关论文
共 20 条
[1]  
Abed Y, 2004, ANTIVIR THER, V9, P577
[2]   Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations [J].
Abed, Y ;
Goyette, N ;
Boivin, G .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (02) :556-559
[3]   Treatment of respiratory virus infections [J].
Abed, Yacine ;
Boivin, Guy .
ANTIVIRAL RESEARCH, 2006, 70 (02) :1-16
[4]  
Aoki FY, 2007, ANTIVIR THER, V12, P603
[5]   Characterization of drug-resistant recombinant influenza A/H1N1 viruses selected in vitro with peramivir and zanamivir [J].
Baz, Mariana ;
Abed, Yacine ;
Boivin, Guy .
ANTIVIRAL RESEARCH, 2007, 74 (02) :159-162
[6]   Activity of the Oral Neuraminidase Inhibitor A-322278 against the Oseltamivir-Resistant H274Y (A/H1N1) Influenza Virus Mutant in Mice [J].
Baz, Mariana ;
Abed, Yacine ;
Nehme, Benjamin ;
Boivin, Guy .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (02) :791-793
[7]  
Brammer L., 2009, Morbidity and Mortality Weekly Report, V58, P115
[8]   Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States [J].
Bright, RA ;
Shay, DK ;
Shu, B ;
Cox, NJ ;
Klimov, AI .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (08) :891-894
[9]  
Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P433
[10]   Distribution of amantadine-resistant H5N1 avian influenza variants in Asia [J].
Cheung, Chung-Lam ;
Rayner, Jane M. ;
Smith, Gavin J. D. ;
Wang, Pui ;
Naipospos, T. S. P. ;
Zhang, Jinxia ;
Yuen, Kwok-Yung ;
Webster, Robert G. ;
Peiris, J. S. Malik ;
Guan, Yi ;
Chen, Honglin .
JOURNAL OF INFECTIOUS DISEASES, 2006, 193 (12) :1626-1629